MedPath

山东淄博新达制药有限公司

Ownership
-
Established
1993-03-11
Employees
-
Market Cap
-
Website
http://www.xincat.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

56

NMPA:56

Drug Approvals

Febuxostat Tablets

Product Name
非布司他片
Approval Number
国药准字H20249271
Approval Date
Nov 5, 2024
NMPA

Azithromycin for Suspension

Product Name
阿奇霉素干混悬剂
Approval Number
国药准字H20094126
Approval Date
May 11, 2024
NMPA

Azithromycin Tablets

Product Name
阿奇霉素片
Approval Number
国药准字H20083479
Approval Date
Apr 17, 2023
NMPA

Ursodeoxycholic Acid Tablets

Product Name
熊去氧胆酸片
Approval Number
国药准字H37023016
Approval Date
Dec 23, 2021
NMPA

Cefixime Capsules

Product Name
头孢克肟胶囊
Approval Number
国药准字H20070310
Approval Date
Dec 20, 2021
NMPA

Lacidophilin Granules

Product Name
乳酸菌素颗粒
Approval Number
国药准字H20213135
Approval Date
Feb 24, 2021
NMPA

Lacidophilin Granules

Product Name
乳酸菌素颗粒
Approval Number
国药准字H20213136
Approval Date
Feb 24, 2021
NMPA

Finasteride Capsules

Product Name
士怡
Approval Number
国药准字H20060969
Approval Date
Feb 20, 2021
NMPA

Ciprofloxacin Hydrochloride Tablets

Product Name
盐酸环丙沙星片
Approval Number
国药准字H20064122
Approval Date
Nov 18, 2020
NMPA

Pioglitazone Hydrochloride Capsules

Product Name
顿灵
Approval Number
国药准字H20060621
Approval Date
Nov 18, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.